Retinoblastoma and p53 gene product expression in breast carcinoma: Immunohistochemical analysis and clinicopathologic correlation

Callahan, 1989, Mutations in human breast cancer: An overview, J Natl Cancer Inst, 81, 1780, 10.1093/jnci/81.23.1780 Trent, 1985, Cytogenetic and molecular biologic alterations in human breast cancer: A review, Br Cancer Res Treat, 5, 221, 10.1007/BF01806017 Hall, 1990, Linkage of early-onset familial breast cancer to chromosome 17q21, Science, 250, 1684, 10.1126/science.2270482 Slamon, 1987, Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, 235, 177, 10.1126/science.3798106 Slamon, 1989, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Varley, 1987, Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinoma correlate with poor short-term prognosis, Oncogene, 1, 423 Escot, 1986, Genetic alteration of the c-myc proto-oncogene (MYC) in human primary breast carcinomas, 83, 4834 Varley, 1988, A common alteration to the int-2 proto-oncogene in DNA from primary breast carcinomas, Oncogene, 3, 87 Ali, 1989, The amplification unit on chromosome 11q13 in aggressive primary human breast tumors contains the bcl-1, int-2, and hst loci, Oncogene, 4, 89 Genuardi, 1989, Distal deletion of chromosome 1p in ductal carcinoma of the breast, Am J Hum Genet, 45, 73 Chen, 1989, Loss of heterozygosity on chromosome 1q in human breast cancer, 86, 7204 Ali, 1989, Presence of two members of c-erbA receptor gene family (c-erbAβ and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p 21–25 in human breast carcinoma, J Natl Cancer Inst, 81, 1815, 10.1093/jnci/81.23.1815 Ali, 1987, Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia, Science, 238, 185, 10.1126/science.3659909 Lundberg, 1987, Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13, 84, 2372 Mackay, 1988, Allele loss on short arm of chromosome 17 in breast cancer, Lancet, 2, 1384, 10.1016/S0140-6736(88)90584-3 Lee, 1987, Human retinoblastoma susceptibility gene: Cloning, identification, and sequence, Science, 235, 1394, 10.1126/science.3823889 Bernards, 1989, Structure and expression of the murine retinoblastoma gene and characterization of its encoded product, 86, 6474 Buchkovich, 1989, The retinoblastoma protein is phosphorylated during specific phases of the cell cycle, Cell, 58, 1097, 10.1016/0092-8674(89)90508-4 Chellapan, 1991, The E2F transcription factor is a cellular target for the RB protein, Cell, 65, 1053, 10.1016/0092-8674(91)90557-F Cavenee, 1983, Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature, 305, 779, 10.1038/305779a0 Cavenee, 1985, Genetic origin of mutations predisposing to retinoblastoma, Science, 228, 501, 10.1126/science.3983638 Hansen, 1985, Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition, 82, 6216 Stratton, 1989, Structural alterations of the RB1 gene in human soft tissue tumours, Br J Cancer, 60, 202, 10.1038/bjc.1989.251 Harbour, 1988, Abnormalities in structure and expression of the human retinoblastoma gene in SCLC, Science, 241, 353, 10.1126/science.2838909 Horowitz, 1989, Point mutational inactivation of the retinoblastoma antioncogene, Science, 243, 937, 10.1126/science.2521957 Cheng, 1990, Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line, Blood, 75, 730, 10.1182/blood.V75.3.730.730 Ginsberg, 1991, Inactivation of the retinoblastoma gene in human lymphoid neoplasms, Blood, 77, 833, 10.1182/blood.V77.4.833.833 Lee, 1988, Inactivation of the retinoblastoma gene in human breast carcinoma, Science, 241, 218, 10.1126/science.3388033 T'Ang, 1988, Structural rearrangement of the retinoblastoma gene in human breast carcinoma, Science, 242, 263, 10.1126/science.3175651 Varley, 1989, The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours, Oncogene, 4, 725 Baker, 1989, Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, Science, 244, 217, 10.1126/science.2649981 Levine, 1991, The p53 tumour suppressor gene, Nature, 351, 453, 10.1038/351453a0 Finlay, 1989, The p53 proto-oncogene can act as a suppressor of transformation, Cell, 57, 1083, 10.1016/0092-8674(89)90045-7 Mulligan, 1990, Mechanisms of p53 loss in human sarcomas, 87, 5863 Wolf, 1984, Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene, Cell, 38, 119, 10.1016/0092-8674(84)90532-4 Vogelstein, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901 Iggo, 1990, Increased expression of mutant forms of p53 oncogene in primary lung cancer, Lancet, 335, 675, 10.1016/0140-6736(90)90801-B Takahashi, 1989, p53: A frequent target for genetic abnormalities in lung cancer, Science, 246, 491, 10.1126/science.2554494 James, 1989, Mitotic recombination of chromosome 17 on astrocytomas, 86, 2858 Meltzer, 1991, Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction, 88, 4976 Hsu, 1991, Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature, 350, 427, 10.1038/350427a0 Kelman, 1989, Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia, Blood, 74, 2318, 10.1182/blood.V74.7.2318.2318 Gaidano, 1991, p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia, 88, 5413 Coles, 1990, Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis, Lancet, 336, 761, 10.1016/0140-6736(90)93236-I Nigro, 1989, Mutations in the p53 gene occur in diverse human tumour types, Nature, 342, 705, 10.1038/342705a0 Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms, Science, 250, 1233, 10.1126/science.1978757 Crawford, 1984, The cellular protein p53 in human tumours, Mol Biol Med, 2, 261 Crawford, 1982, Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer, Int J Cancer, 30, 403, 10.1002/ijc.2910300404 Davidoff, 1991, Maintenance of p53 alterations throughout breast cancer progression, Cancer Res, 51, 2605 Davidoff, 1991, Genetic basis for p53 overexpression in human breast cancer, 88, 5006 Cattoretti, 1988, p53 expression in breast cancer, Int J Cancer, 41, 178, 10.1002/ijc.2910410204 Ostrowski, 1991, p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study, J Pathol, 164, 75, 10.1002/path.1711640113 Chang, 1991, Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors, J Histochem Cytochem, 39, 1281, 10.1177/39.9.1680897 Benedict, 1990, Role of the retinoblastoma gene in the initiation and progression of human cancer, J Clin Invest, 85, 988, 10.1172/JCI114575 Stratton, 1990, Mutation of the p53 gene in human soft tissue sarcomas: Association with abnormalities of the RB1 gene, Oncogene, 5, 1297 Chiang, 1990, Frequent mutations of the p53 tumor suppressor gene in human leukemia T cell lines, Mol Cell Biol, 10, 5502, 10.1128/MCB.10.10.5502 Green, 1989, When the products of oncogenes and anti-oncogenes meet, Cell, 56, 1, 10.1016/0092-8674(89)90975-6